Response to Steroids Predicts Response to Rituximab in Pediatric Chronic Immune Thrombocytopenia

BACKGROUND: Treatment choice in pediatric immune thrombocytopenia (ITP) is arbitrary, because few studies are powered to identify predictors of therapy response. Increasingly, rituximab is becoming a treatment of choice in those refractory to other therapies. METHODS: The objective of this study was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Grace, Rachael F., Bennett, Carolyn M., Ritchey, A. Kim, Jeng, Michael, Thornburg, Courtney D., Lambert, Michele P., Neier, Michelle, Recht, Michael, Kumar, Manjusha, Blanchette, Victor, Klaassen, Robert J., Buchanan, George R., Kurth, Margaret Heisel, Nugent, Diane J., Thompson, Alexis A., Stine, Kimo, Kalish, Leslie A., Neufeld, Ellis J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3863944/
https://ncbi.nlm.nih.gov/pubmed/21674758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.23130
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge